HCR-188

N/A

Report date: 2025/11/27 20:00:08

Base Information

Drug NameHCR-188
Drug Alias NameHCR-188
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of Actionanti-GIP
TargetsGlucose-dependent insulinotropic polypeptide
Therapy Area/IndicationsOverweightObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHelicore Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesHelicore Biopharma Inc
Inactive CompaniesN/A
Active IndicationsObesity
Inactive IndicationsOverweight

Other Information

ATC CodeN/A
Related LinksN/A